/ Dec 13, 2016

Immunotherapy drug gives lung cancer patients four extra months

Most lung cancer patients survived four months longer on an immunotherapy drug than those treated with chemotherapy, according to trial results published Monday. Importantly, they also experienced fewer side effects, researchers reported in The Lancet medical journal. Patients with non-small-cell lung cancer — which represents the ...